| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Leonard E Post is Director at QURE and has filed Form 4s across 3 companies. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 26 sales. Leonard E Post's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
Historically, Leonard E Post's trades have earned a below-average insider score of 40/100 across 23 rated trades. Over a 12-month horizon, 11.8% of those trades were profitable, with an average 12-month return of -61.2%.
The biggest single holding is QURE (~$847K) as Director. The QURE filings lean toward selling, a net 9,802 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | CGON Cg Oncology, Inc. | Director | Sale+OE10b5-1 | 1,000 | $28.84 | $28,840.00 | - | -5.3% | +29.6% | |
| Dec 6, 2024 | CGON Cg Oncology, Inc. | Director | Sale+OE10b5-1 | 1,000 | $34.54 | $34,541.98 | - | -22.0% | +25.2% | |
| Jun 13, 2024 | QURE Uniqure N.V. | Director | Sell | 2,222 | $5.14 | $11,421.08 | -12.2% | +4.2% | +192.2% | |
| Jun 16, 2023 | QURE Uniqure N.V. | Director | Sell | 2,291 | $18.83 | $43,139.53 | -11.2% | -60.6% | -74.9% | |
| Feb 27, 2023 | QURE Uniqure N.V. | Director | Sell | 389 | $19.73 | $7,674.97 | -3.2% | -8.4% | -67.9% | |
| Feb 28, 2022 | QURE Uniqure N.V. | Director | Sell | 795 | $16.64 | $13,228.80 | -20.3% | -15.5% | +23.4% |